November 14, 2022 — Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo urgent percutaneous coronary intervention (PCI), and can lower th

November 10, 2022 —  Biosense Webster, Inc., the global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, announced today that data from a Biosense Webster-sponsored study that compares the risk of dementia in patients with atrial fibrillation (AFib) who were treated with catheter ablation (CA) versus anti-arrhythmic drugs (AAD) was published in the American Heart Journal

November 10, 2022 —  Researchers at the University of Maryland School of Medicine’s (UMSOM) Center for Precision Disease Modeling identified how a specific protein in SARS-CoV-2, the virus responsible for COVID-19, damages heart tissue. They then used a drug to reverse the toxic effects of that protein on the heart. 

November 9, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), left ventricular global

November 9, 2022 — CinCor Pharma, Inc. announced the presentation today of Phase 2 data from its BrigHtn trial as part of the late-breaking science session at the 2022 American Heart Association (AHA) Scientific Sessions. Baxdrostat is a highly selective, once daily oral small molecule inhibitor of aldosterone synthase.